Niagen Bioscience (NAGE)

• Market cap: $520M
• 1 day: -2.98%
• 5 days: 2.84%
• 1 month: -5.1%
• 3 months: -36.18%
• 6 months: -52.27%
• Year to date: 18.8%
• 1 year: 22.83%
• 5 years: 27.9%
• 10 years: 45.31%
• Sector: Healthcare
• Industry: Biotechnology

About: Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Employees: 104